D-0692-2017 Class III Terminated
FDA drug recall D-0692-2017 was initiated by The Harvard Drug Group on Dec 27, 2016 and is designated Class III. Reason for recall: Superpotent Drug; out of specification results for assay (manufacturer) The recall status is terminated (terminated Jul 27, 2017). Affected quantity: 36,990 tablets.
Recall details
- Product Type
- Drugs
- Report Date
- May 10, 2017
- Initiation Date
- Dec 27, 2016
- Termination Date
- Jul 27, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 36,990 tablets
Product description
Aripiprazole Tablets, 2 mg, 30 count unit dose box, Rx only, Manufactured by Apotex Inc., Toronto, Ontario, Canada, Distributed by Major Pharmaceuticals, Livonia, MI NDC 0904-6509-04
Reason for recall
Superpotent Drug; out of specification results for assay (manufacturer)
Distribution pattern
Nationwide and PR
Code information
LOT: T-00601 Exp: 04-2017
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0692-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026